Literature DB >> 12062424

Heteronuclear NMR studies of human serum apolipoprotein A-I. Part I. Secondary structure in lipid-mimetic solution.

Mark Okon1, Philippe G Frank, Yves L Marcel, Robert J Cushley.   

Abstract

The apolipoprotein A-I (apoA-I) solution structure in the presence of sodium dodecyl sulfate (SDS) was determined by combination of chemical shift index and torsion angle likelihood obtained from shift and sequence similarity methods. ApoA-I in lipid-mimetic solution is composed of alpha-helices (residues 8-32, 45-64, 67-77, 82-86, 90-97, 100-118, 122-140, 146-162, 167-205, 210-216 and 221-239), with 2-5 residue irregular segments between helical repeats, and the irregular segment 78-81 within helical repeat 2. ApoA-I is a monomer in the SDS complex and no evidence of interhelical interactions is found. Comparison of the apoA-I and apoA-I(1-186) [Okon et al., FEBS Lett. 487 (2001) 390-396] solution structures revealed that apoA-I undergoes a conformational change around Pro121.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12062424     DOI: 10.1016/s0014-5793(02)02600-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

1.  Conformation and lipid binding of a C-terminal (198-243) peptide of human apolipoprotein A-I.

Authors:  Hongli L Zhu; David Atkinson
Journal:  Biochemistry       Date:  2007-02-13       Impact factor: 3.162

Review 2.  Lipid-free Apolipoprotein A-I Structure: Insights into HDL Formation and Atherosclerosis Development.

Authors:  Xiaohu Mei; David Atkinson
Journal:  Arch Med Res       Date:  2015-06-03       Impact factor: 2.235

3.  Surface pressure-dependent conformation change of apolipoprotein-derived amphipathic α-helices.

Authors:  Matthew A Mitsche; Donald M Small
Journal:  J Lipid Res       Date:  2013-03-25       Impact factor: 5.922

4.  Conformation of dimeric apolipoprotein A-I milano on recombinant lipoprotein particles.

Authors:  Shaila Bhat; Mary G Sorci-Thomas; Laura Calabresi; Michael P Samuel; Michael J Thomas
Journal:  Biochemistry       Date:  2010-06-29       Impact factor: 3.162

5.  Composition and lipid spatial distribution of HDL particles in subjects with low and high HDL-cholesterol.

Authors:  Laxman Yetukuri; Sanni Söderlund; Artturi Koivuniemi; Tuulikki Seppänen-Laakso; Perttu S Niemelä; Marja Hyvönen; Marja-Riitta Taskinen; Ilpo Vattulainen; Matti Jauhiainen; Matej Oresic
Journal:  J Lipid Res       Date:  2010-04-29       Impact factor: 5.922

6.  C-terminus of apolipoprotein A-I removes phospholipids from a triolein/phospholipids/water interface, but the N-terminus does not: a possible mechanism for nascent HDL assembly.

Authors:  Matthew A Mitsche; Donald M Small
Journal:  Biophys J       Date:  2011-07-20       Impact factor: 4.033

7.  Crystal structure of C-terminal truncated apolipoprotein A-I reveals the assembly of high density lipoprotein (HDL) by dimerization.

Authors:  Xiaohu Mei; David Atkinson
Journal:  J Biol Chem       Date:  2011-09-13       Impact factor: 5.157

8.  Role of lipids in spheroidal high density lipoproteins.

Authors:  Timo Vuorela; Andrea Catte; Perttu S Niemelä; Anette Hall; Marja T Hyvönen; Siewert-Jan Marrink; Mikko Karttunen; Ilpo Vattulainen
Journal:  PLoS Comput Biol       Date:  2010-10-28       Impact factor: 4.475

9.  The low-resolution structure of nHDL reconstituted with DMPC with and without cholesterol reveals a mechanism for particle expansion.

Authors:  Valentin Gogonea; Gary S Gerstenecker; Zhiping Wu; Xavier Lee; Celalettin Topbas; Matthew A Wagner; Thomas C Tallant; Jonathan D Smith; Philip Callow; Vitaliy Pipich; Hélène Malet; Guy Schoehn; Joseph A DiDonato; Stanley L Hazen
Journal:  J Lipid Res       Date:  2013-01-23       Impact factor: 5.922

10.  Probing the C-terminal domain of lipid-free apoA-I demonstrates the vital role of the H10B sequence repeat in HDL formation.

Authors:  Xiaohu Mei; Minjing Liu; Haya Herscovitz; David Atkinson
Journal:  J Lipid Res       Date:  2016-06-17       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.